Author

Rachel Heuer

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5028790959

Phase 1 study of lenzilumab, a recombinant anti–human GM-CSF antibody, for chronic myelomonocytic leukemia

2020 · Mrinal M. Patnaik, David A. Sallman, et al. · Blood · 55

A Phase 1 Study of Lenzilumab, a humaneered recombinant Anti-Human Granulocyte-Macrophage Colony- Stimulating Factor (anti-hGM-CSF) Antibody, for Chronic Myelomonocytic Leukemia (CMML)

2019 · Mrinal M Patnaik, David A Sallman, et al. · Blood · 5

Works count: 2

Citation count: 60

H-index: 2

I10-index: 1